80335 Mnchen patent opposition analysis

The comprehensive analysis of 80335 Mnchen opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by 80335 Mnchen

Patent NumberTitleApplicantOpposition DateOpposition Company
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSAug 1, 2024MICHALSKI HTTERAMNN & PARTNER

Top companies who are the clients of 80335 Mnchen